ALKS Craig C Hopkinson sells $5.2M worth of shares
Feb 15, 2025, 5:33 AM
-2.21%
What does ALKS do
Alkermes Plc is a biopharmaceutical company based in Dublin, focused on developing treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder, employing 2,100 people. Its key products include LYBALVI, ARISTADA, and VIVITROL, with ongoing development for neurological disorders and cancer.
Craig C Hopkinson sold 144,419 shares of ALKS on 13 February at $36.02 per share, worth a total of $5.2M. They now own 166,708 ALKS shares, or a 71% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
